BioSpace News Archive

Biotech Bay

More Than 60% of Drug Safety Experts Plan To Use AI to Improve the Speed and Security of Adverse Event Case Processing

Research reveals the life sciences industry is adopting new technologies to automate safety processes and drive down costs, while staying compliant

March 22, 2018
·
4 min read
BioIQ Raises 26.5M to Transform Value-Based Care Delivery for Payers, Providers and Consumers

Proceeds will fuel growth, innovation and transformation of healthcare delivery

March 22, 2018
·
3 min read
FDA

Health Canada Accepts Cardiome’s Xydalba New Drug Submission and Grants Priority Review

Approval Decision Expected in Third Quarter 2018

March 22, 2018
·
6 min read
Business

Peloton Therapeutics, Inc. Appoints Helen S. Kim, M.B.A. and David Chang, M.D., Ph.D. to Board of Directors

Peloton Therapeutics, Inc., announced today the appointment of two new members to the company’s Board of Directors.

March 22, 2018
·
3 min read
Business

LIGHTMED Corporation Appoints Dennis Dowell as Director of Sales and Marketing for North America

Dowell is a sales, marketing and training expert with more than 30 years of professional experience in the ophthalmic industry.

March 22, 2018
·
2 min read
Business

Neogen reports third quarter results

Current year-to-date revenues were $292,965,000, up 12% compared to $262,747,000 for the same period a year ago.

March 22, 2018
·
12 min read
Business

Mike Supple Joins MedeAnalytics as Member of its Board of Directors

MedeAnalytics announced the appointment of Mike Supple as the newest member of its Board of Directors.

March 22, 2018
·
2 min read
Business

Dr. Jason Martin Introduces Lead-Edge Training Program in Partnership with InMode Aesthetic Solutions

Dr. Jason Martin, a leading plastic surgeon has partnered with InMode Aesthetic Solutions to announce the launch of the Mountain West BodyTite Training Center (MWBTC) program.

March 22, 2018
·
2 min read
Pharm Country

The Michael J. Fox Foundation Funds Three Research Teams to Seek Common Biological Pathways Underpinning Environment, Genetics and Aging in Parkinson’s Onset and Progression

$6-million, two-year program to holistically investigate known risk and causal factors toward discovery of common framework underlying onset and progression of Parkinson’s disease

March 22, 2018
·
6 min read
Pharm Country

Oppenheimer & Co. Inc. Concludes Its Twenty-Eighth Annual Healthcare Conference In New York City

Oppenheimer & Co. Inc. recently hosted its 28th Annual Healthcare Conference in New York City on March 20 and 21, 2018.

March 22, 2018
·
2 min read